We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Latest Industry Insights

Inside of an extracellular vesicle.
Industry Insight

Building the Future of Extracellular Vesicle Isolation

Hans van der Voorn tells us about some of the recent progress in the extracellular vesicle-based diagnostics and therapeutics landscape, particularly the need for industrial-scale EV isolation workflows.
Protein structure.
Industry Insight

Expanding the Drug Target Universe: How Next-Generation Proteomics Is Transforming Oncology Research

Cutting-edge mass spectrometry proteomics technologies are accelerating the discovery and validation of novel targets in cancer, opening up new avenues for next-generation cancer therapeutics.
Cancer patient with a line in her arm talking to a medic with a stethoscope around her neck.
Industry Insight

Next-Generation Proteomics Solutions Set To Accelerate Targeted Therapies

Hear how the capabilities of mass spectrometry (MS)-based proteomics are proving themselves in drug development and discovery and what this means for those working in oncology.
A computer-generated image of a DNA double helix.
Industry Insight

Comprehensive Cancer Research Solutions: From Diagnostics to Therapy

At AACR 2023, Technology Networks spoke with Dr. Mark Garner, global cancer segment market manager at Agilent Technologies, to learn how the new SureSelect Cancer CGP assay is empowering the cancer research field.
10th birthday candle and confetti.
Industry Insight

A Decade of DIA and Key Milestones: The 10-Year Anniversary of SWATH DIA

The 10-year anniversary of SWATH DIA signifies a period of immense growth that is only expected to continue to evolve, influencing a wide range of fields. This article explores key milestones for SWATH DIA since its development.
Many different types of oral medication.
Industry Insight

Small Molecule KRAS Inhibitors With Potent Antitumor Activity

In this interview, Technology Networks spoke to Dr. Cameron Pitt to learn more about KRAS as a target for cancer therapeutics, avoiding known resistance mechanisms and the effectiveness of two novel KRAS inhibitors.
Human face looking at an artificial intelligence face.
Industry Insight

Digital Twins and Trial Arms: Is the Future of Single-Arm Oncology Trials Already Here?

In this opinion piece, Dr. Gen Li discusses how AI and predictive analytics are transforming oncology clinical trials.
Connecting hexagons each with a symbol relating to health, medicine and data.
Industry Insight

The Impact of Proteomics on Precision Oncology

To find out more about how proteomics is providing new insights into cancer dynamics and resistance mechanisms, we spoke to Dr. Ofer Sharon, CEO of OncoHost, a precision diagnostics company.
A fluorescent visual aid seen used during surgery.
Industry Insight

A Non-Invasive Treatment for Difficult-To-Treat Pediatric Brain Cancer

In this interview, Technology Networks spoke to Dr. Stuart Marcus, founder and chief medical officer of SonALAsense, to find out how ALA sonodynamic therapy could be a more effective treatment for diffuse intrinsic pontine glioma and recurrent glioblastoma.
Tower Bridge, London.
Industry Insight

The UK Is Facing a Science and Tech Exodus

In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.